Atlas Trials

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Clinical trial NCT03598582 · COMPLETED

Trial details

NCT number
NCT03598582
Sponsor
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2013-01-01
Primary completion
2017-05-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.